Found: 198
Select item for more details and to access through your institution.
Activation of apoptosis signaling eliminates CD34+ progenitor cells in blast crisis CML independent of response to tyrosine kinase inhibitors.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Phase I/II multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4877 in patients with refractory acute myeloid leukemia.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 3, p. 1107, doi. 10.1007/s10637-011-9660-2
- By:
- Publication type:
- Article
MER1, a novel organic arsenic derivative, has potent PML-RAR[alpha]- independent cytotoxic activity against leukemia cells.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Concomitant use of direct-acting antivirals and chemotherapy in hepatitis C virus-infected patients with cancer.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2016, v. 44, n. 11/12, p. 1235, doi. 10.1111/apt.13825
- By:
- Publication type:
- Article
Low-dose interferon-alpha in chronic myeloid leukemia.
- Published in:
- 1995
- By:
- Publication type:
- commentary
Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. The Leukemia Service.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Treatment of Waldenstrom macroglobulinemia with 2-chlorodeoxyadenosine.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Listeriosis in patients with chronic lymphocytic leukemia who were treated with fludarabine and prednisone.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patients.
- Published in:
- 1991
- By:
- Publication type:
- journal article
Standard management of patients with chronic myeloid leukemia.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Leukemia research, 2008.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Practical management of toxicities associated with tyrosine kinase inhibitors in chronic myeloid leukemia.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Optimizing treatment with Bcr-Abl tyrosine kinase inhibitors in Philadelphia chromosome-positive chronic myeloid leukemia: focus on dosing schedules.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Emerging safety issues with imatinib and other Abl tyrosine kinase inhibitors.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
Management of patients with newly diagnosed chronic myeloid leukemia: opportunities and challenges.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
Clinical Pharmacokinetics of the BCR–ABL Tyrosine Kinase Inhibitor Nilotinib.
- Published in:
- Clinical Pharmacology & Therapeutics, 2010, v. 87, n. 2, p. 197, doi. 10.1038/clpt.2009.208
- By:
- Publication type:
- Article
Optimal first-line treatment of chronic myeloid leukemia. How to use imatinib and what role for newer drugs?
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
Jak2 inhibition deactivates Lyn kinase through the SET–PP2A–SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients.
- Published in:
- Oncogene, 2009, v. 28, n. 14, p. 1669, doi. 10.1038/onc.2009.7
- By:
- Publication type:
- Article
Clinical and laboratory changes induced by alpha interferon in chronic lymphocytic leukemia-a pilot study.
- Published in:
- American Journal of Hematology, 1987, v. 24, n. 4, p. 341, doi. 10.1002/ajh.2830240403
- By:
- Publication type:
- Article
CD30 Expression in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 3, p. 307, doi. 10.1016/j.clml.2012.12.006
- By:
- Publication type:
- Article
Treatment of the blastic phase of chronic myelogenous leukemia with mitoxantrone and high-dose cytosine arabinoside.
- Published in:
- 1988
- By:
- Publication type:
- journal article
Mitoxantrone and high-dose cytosine arabinoside in refractory acute myelogenous leukemia.
- Published in:
- 1988
- By:
- Publication type:
- journal article
Characteristics of accelerated disease in chronic myelogenous leukemia.
- Published in:
- 1988
- By:
- Publication type:
- journal article
Rebound peripheral blastosis with subsequent remission during remission induction in a patient with acute promyelocytic leukemia.
- Published in:
- 1988
- By:
- Publication type:
- journal article
Therapy of lymphoid and undifferentiated chronic myelogenous leukemia in blast crisis with continuous vincristine and adriamycin infusions plus high-dose decadron.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Intensive treatment of acute leukemia in adults 70 years of age and older.
- Published in:
- 1987
- By:
- Publication type:
- journal article
The relevance of reticulin stain-measured fibrosis at diagnosis in chronic myelogenous leukemia.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Role of maintenance chemotherapy in acute promyelocytic leukemia.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Clinical and prognostic features of patients with Philadelphia chromosome-positive chronic myelogenous leukemia and extramedullary disease.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Clinical and prognostic features of Philadelphia chromosome-negative chronic myelogenous leukemia.
- Published in:
- 1986
- By:
- Publication type:
- journal article
Early intensification and short-term maintenance chemotherapy does not prolong survival in acute myelogenous leukemia.
- Published in:
- 1986
- By:
- Publication type:
- journal article
Pneumonia with Cunninghamella species in patients with hematologic malignancies. A case report and review of the literature.
- Published in:
- 1986
- By:
- Publication type:
- journal article
The association of specific "favorable" cytogenetic abnormalities with secondary leukemia.
- Published in:
- 1986
- By:
- Publication type:
- journal article
Fusarium. A newly recognized fungal pathogen in immunosuppressed patients.
- Published in:
- 1986
- By:
- Publication type:
- journal article
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM)
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 7, p. 1502, doi. 10.1038/leu.2015.55
- By:
- Publication type:
- Article
Ruxolitinib and survival improvement in patients with myelofibrosis.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 3, p. 739, doi. 10.1038/leu.2014.282
- By:
- Publication type:
- Article
Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 2, p. 312, doi. 10.1038/leu.2014.242
- By:
- Publication type:
- Article
Relationship of different platelet response criteria and patient outcomes in a romiplostim myelodysplastic syndromes trial.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 12, p. 2418, doi. 10.1038/leu.2014.253
- By:
- Publication type:
- Article
Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 7, p. 1543, doi. 10.1038/leu.2014.54
- By:
- Publication type:
- Article
Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 6, p. 1280, doi. 10.1038/leu.2013.355
- By:
- Publication type:
- Article
The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 4, p. 973, doi. 10.1038/leu.2013.312
- By:
- Publication type:
- Article
Myelodysplastic/myeloproliferative neoplasms, unclassifiable (MDS/MPN, U): natural history and clinical outcome by treatment strategy.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 4, p. 958, doi. 10.1038/leu.2014.8
- By:
- Publication type:
- Article
Declining rates of treatment-related mortality in patients with newly diagnosed AML given 'intense' induction regimens: a report from SWOG and MD Anderson.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 2, p. 289, doi. 10.1038/leu.2013.176
- By:
- Publication type:
- Article
Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 11, p. 2177, doi. 10.1038/leu.2013.91
- By:
- Publication type:
- Article
Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 10, p. 2081, doi. 10.1038/leu.2013.165
- By:
- Publication type:
- Article
NRAS mutations with low allele burden have independent prognostic significance for patients with lower risk myelodysplastic syndromes.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 10, p. 2077, doi. 10.1038/leu.2013.160
- By:
- Publication type:
- Article
Toll-like receptor alterations in myelodysplastic syndrome.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1832, doi. 10.1038/leu.2013.180
- By:
- Publication type:
- Article
Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome--positive acute lymphoblastic leukemia.
- Published in:
- 2013
- By:
- Publication type:
- clinical trial
Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 6, p. 1411, doi. 10.1038/leu.2012.324
- By:
- Publication type:
- Article